CCNK and lung carcinoma: Therefore, these results strongly suggest that Cyclin K is a newly identified regulator of Wnt/β-catenin signaling that positively modulates the nuclear β-catenin, providing new insights into the mechanisms by which Cyclin K functions in lung cancer.